FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

NCT01413022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: Fluorouracil
OTHER: laboratory biomarker analysis
OTHER: flow cytometry
OTHER: immunohistochemistry staining method
OTHER: pharmacological study
DRUG: PF-04136309

Sponsor

Washington University School of Medicine

Collaborators

[object Object]